DE102011053775A1 - Verfahren und Vorrichtungen zum Nachweis von Tau-Proteinablagerungen im Auge - Google Patents
Verfahren und Vorrichtungen zum Nachweis von Tau-Proteinablagerungen im Auge Download PDFInfo
- Publication number
- DE102011053775A1 DE102011053775A1 DE201110053775 DE102011053775A DE102011053775A1 DE 102011053775 A1 DE102011053775 A1 DE 102011053775A1 DE 201110053775 DE201110053775 DE 201110053775 DE 102011053775 A DE102011053775 A DE 102011053775A DE 102011053775 A1 DE102011053775 A1 DE 102011053775A1
- Authority
- DE
- Germany
- Prior art keywords
- light emission
- eye
- probes
- retina
- interest
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000034 method Methods 0.000 title claims abstract description 35
- 102000013498 tau Proteins Human genes 0.000 title description 9
- 108010026424 tau Proteins Proteins 0.000 title description 9
- 239000000523 sample Substances 0.000 claims abstract description 65
- 210000001525 retina Anatomy 0.000 claims description 37
- 238000001514 detection method Methods 0.000 claims description 28
- 238000005259 measurement Methods 0.000 claims description 24
- 230000005284 excitation Effects 0.000 claims description 19
- -1 1,3-benzothiazol-2-yl Chemical group 0.000 claims description 14
- 230000004044 response Effects 0.000 claims description 9
- PFYHKVQTYNQKQY-UHFFFAOYSA-N 4,6-bis(ethenyl)pyrimidine Chemical class C=CC1=CC(C=C)=NC=N1 PFYHKVQTYNQKQY-UHFFFAOYSA-N 0.000 claims description 5
- 235000013877 carbamide Nutrition 0.000 claims description 5
- 230000003287 optical effect Effects 0.000 claims description 5
- QGVNJBPLNRZKOX-UHFFFAOYSA-N 2,5-bis(ethenyl)pyrazine Chemical class C=CC1=CN=C(C=C)C=N1 QGVNJBPLNRZKOX-UHFFFAOYSA-N 0.000 claims description 4
- 208000030533 eye disease Diseases 0.000 claims description 4
- JRIJHURMKCXSKF-UHFFFAOYSA-N 2,5-bis[2-(4-hydroxyphenyl)ethenyl]benzonitrile Chemical compound C1=CC(O)=CC=C1C=CC(C=C1C#N)=CC=C1C=CC1=CC=C(O)C=C1 JRIJHURMKCXSKF-UHFFFAOYSA-N 0.000 claims description 3
- 239000004098 Tetracycline Substances 0.000 claims description 3
- 150000007857 hydrazones Chemical class 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- 235000019364 tetracycline Nutrition 0.000 claims description 3
- 150000003522 tetracyclines Chemical class 0.000 claims description 3
- 238000001228 spectrum Methods 0.000 claims description 2
- 229960002180 tetracycline Drugs 0.000 claims description 2
- 229930101283 tetracycline Natural products 0.000 claims description 2
- 229940054066 benzamide antipsychotics Drugs 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 229920001307 poly(hydroxymethylethylene hydroxymethyl formal) Polymers 0.000 description 26
- 150000001875 compounds Chemical class 0.000 description 13
- 208000024827 Alzheimer disease Diseases 0.000 description 11
- 210000004556 brain Anatomy 0.000 description 10
- 238000005286 illumination Methods 0.000 description 10
- 230000003595 spectral effect Effects 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 208000034799 Tauopathies Diseases 0.000 description 7
- 238000003384 imaging method Methods 0.000 description 6
- 238000012014 optical coherence tomography Methods 0.000 description 6
- 238000006073 displacement reaction Methods 0.000 description 5
- 210000002682 neurofibrillary tangle Anatomy 0.000 description 5
- 238000003556 assay Methods 0.000 description 4
- 125000004429 atom Chemical group 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- KBPLFHHGFOOTCA-UHFFFAOYSA-N caprylic alcohol Natural products CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000000877 morphologic effect Effects 0.000 description 4
- 230000004770 neurodegeneration Effects 0.000 description 4
- 208000015122 neurodegenerative disease Diseases 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000013455 Amyloid beta-Peptides Human genes 0.000 description 3
- 108010090849 Amyloid beta-Peptides Proteins 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 201000002212 progressive supranuclear palsy Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- ZCXUVYAZINUVJD-AHXZWLDOSA-N 2-deoxy-2-((18)F)fluoro-alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H]([18F])[C@@H](O)[C@@H]1O ZCXUVYAZINUVJD-AHXZWLDOSA-N 0.000 description 2
- 208000037259 Amyloid Plaque Diseases 0.000 description 2
- 201000011240 Frontotemporal dementia Diseases 0.000 description 2
- 208000003098 Ganglion Cysts Diseases 0.000 description 2
- 241001295925 Gegenes Species 0.000 description 2
- 102000029749 Microtubule Human genes 0.000 description 2
- 108091022875 Microtubule Proteins 0.000 description 2
- 238000004617 QSAR study Methods 0.000 description 2
- 238000001069 Raman spectroscopy Methods 0.000 description 2
- 208000005400 Synovial Cyst Diseases 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 230000008499 blood brain barrier function Effects 0.000 description 2
- 210000001218 blood-brain barrier Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000003850 cellular structure Anatomy 0.000 description 2
- 230000005281 excited state Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 210000004688 microtubule Anatomy 0.000 description 2
- 238000010172 mouse model Methods 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 230000010287 polarization Effects 0.000 description 2
- 210000003994 retinal ganglion cell Anatomy 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- JADVWWSKYZXRGX-UHFFFAOYSA-M thioflavine T Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C1=[N+](C)C2=CC=C(C)C=C2S1 JADVWWSKYZXRGX-UHFFFAOYSA-M 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- BUHVIAUBTBOHAG-FOYDDCNASA-N (2r,3r,4s,5r)-2-[6-[[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]amino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound COC1=CC(OC)=CC(C(CNC=2C=3N=CN(C=3N=CN=2)[C@H]2[C@@H]([C@H](O)[C@@H](CO)O2)O)C=2C(=CC=CC=2)C)=C1 BUHVIAUBTBOHAG-FOYDDCNASA-N 0.000 description 1
- 238000010176 18-FDG-positron emission tomography Methods 0.000 description 1
- IAVCEBMLYVGBLA-UHFFFAOYSA-N 2-[1-[6-[2-fluoroethyl(methyl)amino]naphthalen-2-yl]ethylidene]propanedinitrile Chemical compound C1=C(C(C)=C(C#N)C#N)C=CC2=CC(N(CCF)C)=CC=C21 IAVCEBMLYVGBLA-UHFFFAOYSA-N 0.000 description 1
- BQZGCWCTLLWQOS-UHFFFAOYSA-N 3,5-bis(ethenyl)-1h-pyrazole Chemical class C=CC=1C=C(C=C)NN=1 BQZGCWCTLLWQOS-UHFFFAOYSA-N 0.000 description 1
- QQJXQFOVIYYLMI-UHFFFAOYSA-N 3,6-bis(ethenyl)pyridazine Chemical class C=CC1=CC=C(C=C)N=N1 QQJXQFOVIYYLMI-UHFFFAOYSA-N 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 208000036632 Brain mass Diseases 0.000 description 1
- 208000011990 Corticobasal Degeneration Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000000609 Pick Disease of the Brain Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 108090000185 alpha-Synuclein Proteins 0.000 description 1
- 102000003802 alpha-Synuclein Human genes 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 230000013742 energy transducer activity Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000004424 eye movement Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000009760 functional impairment Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical class COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000006951 hyperphosphorylation Effects 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N n-Octanol Natural products CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 210000002241 neurite Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- HGASFNYMVGEKTF-UHFFFAOYSA-N octan-1-ol;hydrate Chemical compound O.CCCCCCCCO HGASFNYMVGEKTF-UHFFFAOYSA-N 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 238000002600 positron emission tomography Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical class C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- 238000001161 time-correlated single photon counting Methods 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/1025—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for confocal scanning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/12—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes
- A61B3/1225—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes using coherent radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0062—Arrangements for scanning
- A61B5/0066—Optical coherence imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
- A61B5/4088—Diagnosing of monitoring cognitive diseases, e.g. Alzheimer, prion diseases or dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4842—Monitoring progression or stage of a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6408—Fluorescence; Phosphorescence with measurement of decay time, time resolved fluorescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B21/00—Microscopes
- G02B21/0004—Microscopes specially adapted for specific applications
- G02B21/0012—Surgical microscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/102—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for optical coherence tomography [OCT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0062—Arrangements for scanning
- A61B5/0068—Confocal scanning
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Surgery (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Radiology & Medical Imaging (AREA)
- Physiology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Optics & Photonics (AREA)
- Hospice & Palliative Care (AREA)
- Developmental Disabilities (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Eye Examination Apparatus (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE201110053775 DE102011053775A1 (de) | 2011-09-20 | 2011-09-20 | Verfahren und Vorrichtungen zum Nachweis von Tau-Proteinablagerungen im Auge |
| PCT/EP2012/068343 WO2013041522A1 (fr) | 2011-09-20 | 2012-09-18 | Procédés et dispositifs pour déceler des dépôts de protéines tau dans l'oeil |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE201110053775 DE102011053775A1 (de) | 2011-09-20 | 2011-09-20 | Verfahren und Vorrichtungen zum Nachweis von Tau-Proteinablagerungen im Auge |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE102011053775A1 true DE102011053775A1 (de) | 2013-03-21 |
Family
ID=46888442
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE201110053775 Ceased DE102011053775A1 (de) | 2011-09-20 | 2011-09-20 | Verfahren und Vorrichtungen zum Nachweis von Tau-Proteinablagerungen im Auge |
Country Status (2)
| Country | Link |
|---|---|
| DE (1) | DE102011053775A1 (fr) |
| WO (1) | WO2013041522A1 (fr) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108227173A (zh) * | 2016-12-22 | 2018-06-29 | 阿诺德和里克特电影技术公司 | 电子显微镜 |
| DE102022131803A1 (de) | 2022-11-30 | 2024-06-06 | Rheinische Friedrich-Wilhelms-Universität Bonn, Körperschaft des öffentlichen Rechts | Verfahren und Bildgebungseinrichtung zur in-vivo Erfassung von Autofluoreszenz eines Augenhintergrundes |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018026683A1 (fr) * | 2016-08-01 | 2018-02-08 | Cognoptix, Inc. | Système et procédé de détection de la protéine tau dans un tissu oculaire |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19920158A1 (de) | 1999-04-29 | 2000-11-02 | Univ Schiller Jena | Verfahren und Anordnung zur Bestimmung von Fluorophoren an Objekten, insbesondere am lebenden Augenhintergrund |
| DE10145823A1 (de) | 2001-09-13 | 2003-04-10 | Univ Schiller Jena | Verfahren zur Auswertung intensitätsschwacher, zeitaufgelöster Fluoreszenzbilder |
| DE10330716A1 (de) | 2003-07-03 | 2005-02-17 | Carl Zeiss Jena Gmbh | Verfahren und Anordnung zur Eliminierung von Falschlicht |
| DE10347389A1 (de) | 2003-07-03 | 2005-05-19 | Carl Zeiss Jena Gmbh | Anordnung zur Eliminierung von Falschlicht |
| DE102004053730A1 (de) | 2004-11-06 | 2006-05-24 | Carl Zeiss Jena Gmbh | Verfahren und Anordnung zur Unterdrückung von Falschlicht |
| DE102006031177A1 (de) | 2006-07-06 | 2008-01-10 | Carl Zeiss Microimaging Gmbh | Verfahren und Vorrichtung zur Erzeugung eines Bildes einer dünnen Schicht eines Objekts |
| WO2011038892A1 (fr) | 2009-09-30 | 2011-04-07 | Carl Zeiss Meditec Ag | Procédé et dispositif de détection de dépôts dans l'oeil |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6485413B1 (en) * | 1991-04-29 | 2002-11-26 | The General Hospital Corporation | Methods and apparatus for forward-directed optical scanning instruments |
| US7884945B2 (en) * | 2005-01-21 | 2011-02-08 | Massachusetts Institute Of Technology | Methods and apparatus for optical coherence tomography scanning |
| US8419186B2 (en) * | 2009-09-30 | 2013-04-16 | Nidek Co., Ltd. | Fundus observation apparatus |
-
2011
- 2011-09-20 DE DE201110053775 patent/DE102011053775A1/de not_active Ceased
-
2012
- 2012-09-18 WO PCT/EP2012/068343 patent/WO2013041522A1/fr active Application Filing
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19920158A1 (de) | 1999-04-29 | 2000-11-02 | Univ Schiller Jena | Verfahren und Anordnung zur Bestimmung von Fluorophoren an Objekten, insbesondere am lebenden Augenhintergrund |
| DE10145823A1 (de) | 2001-09-13 | 2003-04-10 | Univ Schiller Jena | Verfahren zur Auswertung intensitätsschwacher, zeitaufgelöster Fluoreszenzbilder |
| DE10330716A1 (de) | 2003-07-03 | 2005-02-17 | Carl Zeiss Jena Gmbh | Verfahren und Anordnung zur Eliminierung von Falschlicht |
| DE10347389A1 (de) | 2003-07-03 | 2005-05-19 | Carl Zeiss Jena Gmbh | Anordnung zur Eliminierung von Falschlicht |
| DE102004053730A1 (de) | 2004-11-06 | 2006-05-24 | Carl Zeiss Jena Gmbh | Verfahren und Anordnung zur Unterdrückung von Falschlicht |
| DE102006031177A1 (de) | 2006-07-06 | 2008-01-10 | Carl Zeiss Microimaging Gmbh | Verfahren und Vorrichtung zur Erzeugung eines Bildes einer dünnen Schicht eines Objekts |
| WO2011038892A1 (fr) | 2009-09-30 | 2011-04-07 | Carl Zeiss Meditec Ag | Procédé et dispositif de détection de dépôts dans l'oeil |
Non-Patent Citations (2)
| Title |
|---|
| Ertl, P. et al., Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties, J. Med. Chem., 2000, 43, 3714-3717 |
| Lockhart, et al., The Journal of Biological Chemistry, 280, 7677-7684 vom 4. März 2005 unter Material und Methoden |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108227173A (zh) * | 2016-12-22 | 2018-06-29 | 阿诺德和里克特电影技术公司 | 电子显微镜 |
| CN108227173B (zh) * | 2016-12-22 | 2021-09-28 | 阿瑞医疗有限公司 | 电子显微镜 |
| DE102022131803A1 (de) | 2022-11-30 | 2024-06-06 | Rheinische Friedrich-Wilhelms-Universität Bonn, Körperschaft des öffentlichen Rechts | Verfahren und Bildgebungseinrichtung zur in-vivo Erfassung von Autofluoreszenz eines Augenhintergrundes |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013041522A1 (fr) | 2013-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2566380B1 (fr) | Procédé d'imagerie de l'amyloïde bêta de la rétine de l'oeil en lien avec la maladie d'alzheimer | |
| EP1906811B1 (fr) | Dispositif et procede pour realiser un examen d'un fond d'oeil et etablir, sur la base de ce dernier, une documentation et/ou un diagnostic | |
| EP1015888B1 (fr) | Procede pour mesurer l'association des structures particulaires de depots proteiques pathologiques | |
| DE102013008278B4 (de) | Verfahren und Vorrichtung zur 3 D-Vermessung der Hautoberfläche und oberflächennaher Hautschichten | |
| DE102009043750A1 (de) | Verfahren und Vorrichtung zur Detektion von Ablagerungen im Auge | |
| US20210282643A1 (en) | System And Method For Detecting Tau Protein In Ocular Tissue | |
| JP5672058B2 (ja) | スペクトルデータ解析装置、生体内物質検出システム及び生体内物質検出方法 | |
| DE102011053775A1 (de) | Verfahren und Vorrichtungen zum Nachweis von Tau-Proteinablagerungen im Auge | |
| WO1988009145A1 (fr) | Agencement de mesure de valeurs d'etat de surfaces de tissus organiques | |
| DE102007025425A1 (de) | Verfahren und Vorrichtung zur Eliminierung störender Fluoreszenz bei der Fluoreszenzauswertung von Objekten, beispielsweise des Augenhintergrundes | |
| EP1782044B1 (fr) | Procédé et dispositif pour la séparation et la détermination précise d'un fluorophore d'un objet agissant localement | |
| DE102017129519A1 (de) | Anordnung und Verfahren zur simultanen Messung der Fluoreszenz einzelner Schichten, beispielsweise dem Augenhintergrund | |
| WO2013041521A1 (fr) | Procédés et dispositifs pour effectuer un examen de l'oeil | |
| DE10251345B4 (de) | Verfahren und Vorrichtung zur Untersuchung von Schichten von Geweben in lebenden Tieren mit einem Mikroskop | |
| WO2010025715A2 (fr) | Procédé permettant la détermination exacte de la fluorescence dans un système stratifié, tel que l’oeil par exemple | |
| WO2009018953A2 (fr) | Procédé et dispositif de détermination des conditions d'état d'un objet à étudier et de mesure de fluorescence sur l'œil | |
| Sunder et al. | Optical spectroscopy and microscopy techniques for assessment of neurological diseases | |
| Vienola et al. | Near infrared autofluorescence imaging of retinal pigmented epithelial cells using 663 nm excitation | |
| JP2007127592A (ja) | アミロイド蓄積性疾患の新規診断用装置およびその操作方法 | |
| KR101939956B1 (ko) | 반사분광법을 이용한 말이집이 형성된 신경 축삭의 나노 구조 분석 방법 | |
| DE102017109856A1 (de) | Verfahren zur Bestimmung des Alters der Linse | |
| DE112016004434T5 (de) | Verfahren zum raffinieren von reinem thioflavin t, verfahren zum herstellen von reinem thioflavin t, zusammensetzung, die thioflavin t enthält, und verfahren zum nachweisen von amyloid | |
| WO2023283637A2 (fr) | Méthode de détection de l'amylose rétinienne et de la tauopathie faisant intervenir une imagerie hyperspectrale instantanée et/ou une tomographie par cohérence optique hyperspectrale instantanée | |
| DE202018102134U1 (de) | Mikroskop zur verbesserten Messung von Anzahl und Bindungen von Molekülen | |
| KR20180000252A (ko) | 반사분광법을 이용한 말이집이 형성된 신경 축삭의 나노 구조 분석 방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R012 | Request for examination validly filed | ||
| R016 | Response to examination communication | ||
| R002 | Refusal decision in examination/registration proceedings | ||
| R003 | Refusal decision now final |